Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial

Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page’s displayed platform revision/version was updated from v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:16:10.000Z thumbnail image
  3. Check
    26 days ago
    No Change Detected
  4. Check
    47 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the revision history.
    Difference
    0.0%
    Check dated 2026-03-21T09:17:16.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2 revision.
    Difference
    0.0%
    Check dated 2026-03-06T18:47:21.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed. This is a minor metadata/version update and does not alter study details or page functionality.
    Difference
    0.0%
    Check dated 2026-02-13T12:26:48.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision notice updated: added Revision: v3.4.1 and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T15:08:34.000Z thumbnail image
  8. Check
    113 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 in the page metadata.
    Difference
    0.0%
    Check dated 2026-01-15T03:08:27.000Z thumbnail image

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.